TABLE 3 Current Contraceptive Use Among Non-Pregnant, Non-Breastfeeding Women at Baseline (January–March 2014) and Endline (June–July 2014), Selected Counties of Liberia
Baseline (N = 546)Endline (N = 470)Average Marginal Effects (95% CI)aP Value
Control (n = 232)Treatment (n = 314)P ValueControl (n = 215)Treatment (n = 255)P Value
Short-acting methods
 Injectable56 (24.14)76 (24.20).9965 (30.23)62 (24.31).15-0.05 (-0.13, 0.04)0.27
 Male condom19 (8.19)29 (9.24).6718 (8.37)28 (10.98).340.03 (-0.0, 0.93).37
 Pill53 (22.84)53 (16.88).0833 (15.35)60 (23.53).030.08 (0.00, 0.17).06
 Female condom1 (0.43)0 (0.00).240 (0.00)1 (0.39).21
Long-acting methods
 Implant9 (3.88)17 (5.41).4116 (7.44)39 (15.29).010.09 (0.03, 0.16)<.01
 Female sterilization1 (0.43)1 (0.32).830 (0.00)0 (0.00)>.99
 Male sterilization0 (0.00)0 (0.00)>.990 (0.00)0 (0.00)>.99
 IUD0 (0.00)0 (0.00)>.990 (0.00)0 (0.00)>.99
Any long-acting or permanent method10 (4.31)18 (5.73).6316 (7.44)39 (15.29).010.10 (0.05, 0.16)<.01
Any modern method123 (53.02)159 (50.64).58119 (55.35)170 (66.67).010.13 (0.04, 0.22)<.01
Traditional methods
 Rhythm4 (1.72)4 (1.27).678 (3.72)7 (2.75).55
 Other traditional4 (1.72)0 (0.00).021 (0.47)3 (1.18).40
  • Abbreviations: CI, confidence interval; IUD, intrauterine device.

  • Data reported as No. (%) except when otherwise noted.

  • a Estimations for some methods couldnot be calculated because of the small number of users in the sample.